scholarly journals Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects

2018 ◽  
Vol 235 (10) ◽  
pp. 3017-3030 ◽  
Author(s):  
Ruin Moaddel ◽  
Michelle Shardell ◽  
Mohammed Khadeer ◽  
Jacqueline Lovett ◽  
Bashkim Kadriu ◽  
...  
2021 ◽  
Vol 5 (2) ◽  
pp. 238-245
Author(s):  
Oloruntoba A. Ekun

Background: A link between major depressive disorder (MDD) and haematological as well as co-agulation disorders has been postulated. This study aims to evaluate haematological and haemostatic changes among Nigerians with major depressive disorder Methods: Two hundred volunteers consisting of an equal number of individuals diagnosed with major depressive disorder (MDD) based on DMS-IV criteria and apparently healthy control participated in this study. The blood sample was collected into tri-sodium citrate K2EDTA bottles respectively and was evaluated for some haemostatic parameters , using ELISA, Clauss, Quick’s One Stage, Proctor and Rapaport’s methods. Results: The mean WBC, hemoglobin and differential lymphocyte were significantly higher among MDD total volunteers (p < 0.001). The red cell indices and platelet count were lower among MDD (p <0.001). Also the prothrombin time (PT), fibrinogen, protein-C and erythrocytes sedimentation rate (ESR) were all raised (p <0.001) among volunteers with MDD. Positive associations existed be-tween MCV and RBC (r: 0.364; p<0.001), PT and APTT (r: 0.319 p <0.001), APTT and fibrinogen (r: 0.239, p = 0.017) as well as PT and fibrinogen (r: 0.275 p = 0.006) at 95% confidence interval. Conclusion: Changes in total leucocytes count, lymphocytes values and haemostatic parameters among volunteers with depression may impacts deleterious effects on the immune response as well as haemostatic homeostasis, while decreased red cell indices may suggest occult nutritional anaemia.


2018 ◽  
Vol 39 (8) ◽  
pp. 1623-1634 ◽  
Author(s):  
Rajapillai LI Pillai ◽  
Mengru Zhang ◽  
Jie Yang ◽  
J John Mann ◽  
Maria A Oquendo ◽  
...  

In most positron emission tomography (PET) molecular brain imaging studies, regions of interest have been defined anatomically and examined in isolation. However, by defining regions based on physiology and examining relationships between them, we may derive more sensitive measures of receptor abnormalities in conditions such as major depressive disorder (MDD). Using an average of 52 normalized binding potential maps, acquired using radiotracer [11C]-WAY100635 and full arterial input analysis, we identified two molecular volumes of interest (VOIs) with contiguously high serotonin 1A receptor (5-HT1A) binding sites: the olfactory sulcus (OLFS) and a band of tissue including piriform, olfactory, and entorhinal cortex (PRF). We applied these VOIs to a separate cohort of 25 healthy control males and 16 males with MDD who received [11C]-WAY100635 imaging. Patients with MDD had significantly higher binding than controls in both VOIs, ( p < 0.01). To identify potential homeostatic disruptions in MDD, we examined molecular connectivity, i.e. the correlation between binding of raphe nucleus (RN) 5-HT1A autoreceptors and post-synaptic receptors in molecular VOIs. Molecular connectivity was significant in healthy controls ( p < 0.01), but not in patients with MDD. This disruption in molecular connectivity allowed identification of MDD cases with high sensitivity (81%) and specificity (88%).


PLoS ONE ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. e91076 ◽  
Author(s):  
Timothy R. Powell ◽  
Peter McGuffin ◽  
Ursula M. D'Souza ◽  
Sarah Cohen-Woods ◽  
Georgina M. Hosang ◽  
...  

2020 ◽  
Author(s):  
Suqian Duan ◽  
Andrew Lawrence ◽  
Lucia Valmaggia ◽  
Jorge Moll ◽  
Roland Zahn

AbstractBackgroundPersisting self-blaming emotional biases were previously associated with vulnerability to major depressive disorder (MDD). More specifically self-contempt/disgust biases distinguished remitted MDD, compared with never-depressed control participants. The contribution of action tendencies to MDD vulnerability and their relationship with blame-related emotions to prepare for subsequent behaviour is elusive. Here, we investigated whether maladaptive action tendencies such as “creating a distance from oneself” and “hiding” are associated with MDD vulnerability, as well as with self-disgust/contempt and shame respectively.Methods76 participants with medication-free remitted MDD and 44 healthy control (HC) participants without a personal or family history of MDD completed the value-related moral sentiment task, which measured their blame-related emotions during hypothetical social interactions and a novel task to assess their blame-related action tendencies.ResultsAs predicted, the MDD group exhibited a higher proneness to feeling like hiding and creating a distance from themselves compared with the HC group. Interestingly, apologising for one’s wrongdoing, was associated with all self-blaming emotions including shame, guilt, self-contempt/disgust and self-indignation, but was more common in HC. In contrast, apologising and perceiving to be in control of one’s friend’s wrongdoings were more common in MDD. Although shame was indeed associated with hiding, this was also true of guilt. Self-disgust/contempt was associated with attacking rather than creating a distance from oneself.ConclusionsMDD vulnerability was associated with specific maladaptive action tendencies which were not clearly predicted by the type of emotion, thus unveiling novel cognitive markers and neurocognitive treatment targets.General Scientific summaryThis study confirmed the hypothesis that specific maladaptive action tendencies related to self-blame, such as feeling like hiding and feeling like creating a distance from oneself, were distinctive of people with major depressive disorder, even on remission of symptoms. These action tendencies were not clearly predicted by the type of emotion experienced, showing the importance of assessing them directly. This calls for novel psychological and neurocognitive treatments specifically aiming at maladaptive action tendencies which have so far not been directly addressed in standard assessments and treatments.


2014 ◽  
Vol 10 (11) ◽  
pp. 2994-3001 ◽  
Author(s):  
Juan Li ◽  
Ge Tang ◽  
Ke Cheng ◽  
Deyu Yang ◽  
Guanghui Chen ◽  
...  

Major depressive disorder (MDD) is a debilitating mood disorder with various etiopathological hypotheses.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chia-Min Chen ◽  
Chia-Yu Kuo ◽  
Meng-Ni Wu ◽  
Jen-Yu Hung ◽  
Chung-Yao Hsu ◽  
...  

AbstractThe association between sleep apnea (SA) and depression had been reported in a few previous studies. However, whether SA increases the risk of major depressive disorder (MDD) has not been studied comprehensively in a large-scale study. We performed this population-based cohort study to assess the association between SA and MDD. We identified adult patients having SA from the Taiwan National Health Insurance Research Database and excluded those having MDD before SA diagnosis. Thirty control subjects were randomly selected to match to each SA patient by age and sex. Totally, 10,259 SA patients were matched to 102,590 control subjects. The incidence rate and cumulative incidence of MDD were significantly higher in SA patients than in the control subjects (both p < 0.0001). Multivariable Cox regression analysis showed that SA remained an independent risk factor for incident MDD after adjusting for age, sex, residency, income level, and comorbidities (hazard ratio = 2.9 [95% CI 2.8–3.1], p < 0.0001). In summary, SA patients have an increased risk to develop MDD. Physicians caring for SA patients must pay attention to their psychosocial health status.


2022 ◽  
Vol 2022 ◽  
pp. 1-10
Author(s):  
Yang Du ◽  
Ji-Hui Dong ◽  
Lei Chen ◽  
Hua Liu ◽  
Guang-En Zheng ◽  
...  

Background. Exosomes are extracellular vesicles that play important roles in various physiological and pathological functions. Previous studies have demonstrated that exosome-derived contents are promising biomarkers to inform the pathogenesis and diagnosis of major depressive disorder and schizophrenia. Methods. We used ultraperformance liquid chromatography-tandem mass spectrometry to analyze the differentially expressed metabolites in serum exosomes of patients with bipolar disorder (BD) and evaluated the potential of exosomal metabolites as biomarkers for BD. Results. Our results showed 26 differentially expressed serum exosomal metabolites in patients with BD ( n = 32 ) when compared with healthy control (HC) subjects ( n = 40 ), and these differentially expressed metabolites were enriched in pathways related to sugar metabolism. We then utilized random forest classifier and identified 15 exosomal metabolites that can be used to classify samples from patients with BD and HC subjects with 0.838 accuracy (95% CI, 0.604–1.00) in the training set of participants. These 15 metabolites showed excellent performance in differentiating between patients with BD and HC subjects in the testing set of participants, with 0.971 accuracy (95% CI, 0.865–1.00). Importantly, the 15 exosomal metabolites also showed good to excellent performance in differentiating between BD patients and other major psychiatric diseases (major depressive disorder and schizophrenia). Conclusion. Collectively, our findings for the first time revealed a potential role of exosomal metabolite dysregulations in the onset and/or development of BD and suggested that blood exosomal metabolites are strong candidates to inform the diagnosis of BD.


Sign in / Sign up

Export Citation Format

Share Document